KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teradyne (TER) EBT: 2009-2025

Historic EBT for Teradyne (TER) over the last 17 years, with Q3 2025 value amounting to $148.1 million.

  • Teradyne's EBT fell 684.6% to $148.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $521.5 million, marking a year-over-year decrease of 1177.71%. This contributed to the annual value of $609.1 million for FY2024, which is 1589.01% up from last year.
  • Teradyne's EBT amounted to $148.1 million in Q3 2025, which was down 684.6% from $96.6 million recorded in Q2 2025.
  • Teradyne's 5-year EBT high stood at $384.0 million for Q3 2021, and its period low was $72.9 million during Q1 2024.
  • Moreover, its 5-year median value for EBT was $159.0 million (2024), whereas its average is $184.2 million.
  • As far as peak fluctuations go, Teradyne's EBT soared by 7673.35% in 2021, and later plummeted by 5599.01% in 2025.
  • Quarter analysis of 5 years shows Teradyne's EBT stood at $255.2 million in 2021, then fell by 23.49% to $195.2 million in 2022, then decreased by 28.39% to $139.8 million in 2023, then increased by 12.87% to $157.8 million in 2024, then dropped by 6.15% to $148.1 million in 2025.
  • Its last three reported values are $148.1 million in Q3 2025, $96.6 million for Q2 2025, and $119.0 million during Q1 2025.